Adi Renbaum

Adi Renbaum, MBA is president of ANR Consulting in Washington DC, a reimbursement and market access strategy firm advising MedTech, AI-enabled and digital health companies. For more than 25 years, Ms. Renbaum has guided reimbursement strategies and implementation of the essential elements of market access – coverage, coding and payment – for dozens of new devices and diagnostic products launched in the U.S. Ms. Renbaum is a national expert in medical policy development and pricing/contracting between commercial health plans and MedTech companies via her role as Co-Director of the Medical Director Leadership Council of NAMCP. In addition, she has extensive experience with Medicare coverage and payment policies, including three terms on Medicare’s MEDCAC advisory committee for CMS’s national Coverage Analysis Group. Ms. Renbaum actively engages with specialty medical societies and has secured new AMA CPT codes for numerous new technologies and physician procedures, including the first novel AI-enabled diagnostic imaging procedure code reimbursed by CMS. She also has published and spoken on reimbursement policy issues across a variety of therapeutic areas and conducts due diligence of investment targets for a number of private equity and investment firms.